Candesartan attenuates angiogenesis in hepatocellular carcinoma via downregulating AT1R/VEGF pathway (Q38738715)

From Wikidata
Jump to navigation Jump to search
scientific article published on 28 July 2016
edit
Language Label Description Also known as
English
Candesartan attenuates angiogenesis in hepatocellular carcinoma via downregulating AT1R/VEGF pathway
scientific article published on 28 July 2016

    Statements

    Candesartan attenuates angiogenesis in hepatocellular carcinoma via downregulating AT1R/VEGF pathway (English)
    28 July 2016

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit